Kerri St George, PA
Physician Assistant · Springfield, MANPI 1114031739
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.5% of the total across 854 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 17.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 854 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Pharming Healthcare, Inc.$2K
- Pfizer$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- plus $7K from 30 others
What the payments were for
- Speaking & faculty fees$1,1256%
- Food & beverage$16,53293%
- Education$2061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 144 | $3,202 |
| GSK | 117 | $1,985 |
| Pharming Healthcare, Inc. | 22 | $1,561 |
| Pfizer | 90 | $1,558 |
| Regeneron Healthcare Solutions, Inc. | 69 | $1,424 |
| Sanofi | 55 | $1,011 |
| CSL Behring | 50 | $985 |
| Genentech USA, Inc. | 45 | $865 |
| Novartis | 50 | $754 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $703 |
| Amgen(2 entities) | 34 | $576 |
| Grifols USA, LLC | 25 | $507 |
| Boehringer Ingelheim | 21 | $388 |
| LEO Pharma Inc. | 13 | $307 |
| Blueprint Medicines Corporation | 8 | $229 |
| Incyte Corporation | 9 | $222 |
| Aimmune Therapeutics, Inc. | 9 | $214 |
| AbbVie | 7 | $202 |
| Covis Pharma GmbH | 8 | $159 |
| Kaleo, Inc. | 7 | $150 |
| Sanofi-aventis U.S. LLC | 3 | $108 |
| Lilly USA, LLC | 6 | $106 |
| Teva Pharmaceuticals USA, Inc. | 5 | $96 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $83 |
| GC Biopharma USA, Inc. | 3 | $79 |
| USWM, LLC | 2 | $59 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Greer Laboratories, Inc. | 2 | $45 |
| Biocryst US Sales Co., LLC | 2 | $39 |
| Galderma Laboratories, L.p. | 2 | $38 |
| Verona Pharma, Inc. | 2 | $36 |
| Phadia US Inc. | 2 | $31 |
| Organon | 1 | $31 |
| Cycle Pharmaceuticals Inc | 1 | $25 |
| Bio Products Laboratory USA, Inc. | 1 | $20 |
| Invivyd Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$17,863 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 122 | $405,367 |
| Dupixent SyringeDupilumab | 102 | $374,858 |
| Dupixent PenDupilumab | 31 | $115,709 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 94 | $86,056 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 17 | $85,329 |
| NucalaMepolizumab | 24 | $83,763 |
| TezspireTezepelumab-Ekko | 18 | $71,937 |
| Breo ElliptaFluticasone/Vilanterol | 53 | $24,428 |
| Spiriva RespimatTiotropium Bromide | 23 | $19,235 |
| Epinephrine | 66 | $14,793 |
| DuleraMometasone/Formoterol | 22 | $13,932 |
| Advair HfaFluticasone Propion/Salmeterol | 25 | $10,472 |
| Wixela InhubFluticasone Propion/Salmeterol | 56 | $8,872 |
| Arnuity ElliptaFluticasone Furoate | 20 | $7,992 |
| QnaslBeclomethasone Dipropionate | 15 | $7,874 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Arnuity Ellipta, Incruse Ellipta | $1,985 | $207,526203 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $703 | $85,32917 claims |
| AstraZenecaTezspire, Symbicort | $3,202 | $78,56038 claims |
| Boehringer IngelheimSpiriva Respimat | $388 | $19,23523 claims |
| Teva Pharmaceuticals USA, Inc.Qnasl | $96 | $7,87415 claims |
| Cycle Pharmaceuticals IncCromolyn Sodium | $25 | $6,16324 claims |
| Covis Pharma GmbHAlvesco | $159 | $6,07513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.
Other physician assistant in Springfield
- Stacey PanasciSpringfield$113K
- Leslie SmithSpringfield$49K
- Cassandra AyreSpringfield$15K
- Marianne LangloisSpringfield$9K
- Christopher MasseyWilbraham$190K
- Lizabeth O ConnorEverett$182K
- Kimberly ComeauSwampscott$120K
- Jason RandWaltham$99K
- Karen ChunEast Boston$70K
- David PeckhamQuincy$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.